Latest Ratios: P/E Ratio -0.5x · EV/EBITDA N/A · ROE -82.1%. (2021–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Market Cap | $39M | $71M | — | — | — | — |
| Enterprise Value | $117M | $149M | — | — | — | — |
| P/E Ratio → | -0.49 | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — |
| P/B Ratio | 0.33 | 0.78 | — | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | 480.5% | 480.5% | 31.2% | 21.0% | 57.5% | 118.1% |
| Operating Margin | 717.0% | 717.0% | 15.3% | 5.9% | 15.8% | 150.7% |
| Net Profit Margin | 489.9% | 489.9% | 2.9% | -7.7% | 95.8% | 130.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| ROE | -82.1% | -82.1% | 10.2% | -28.8% | 124.6% | 187.6% |
| ROA | -3.7% | -3.7% | 0.3% | -1.0% | 3.0% | 1.7% |
| ROIC | -40.0% | -40.0% | 16.1% | 6.4% | 4.4% | 24.2% |
| ROCE | -8.9% | -8.9% | 7.9% | 3.6% | 2.2% | 9.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Debt / Equity | 1.03 | 1.03 | 1.62 | 1.47 | 1.74 | 5.72 |
| Debt / EBITDA | — | — | 2.73 | 5.56 | 12.77 | 2.57 |
| Net Debt / Equity | — | 0.86 | 0.12 | -0.27 | 0.69 | 2.84 |
| Net Debt / EBITDA | — | — | 0.20 | -1.02 | 5.02 | 1.28 |
| Debt / FCF | — | — | 0.24 | -0.14 | 0.36 | — |
| Interest Coverage | -5.25 | -5.25 | 1.77 | -1.64 | 14.68 | 11.78 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 36.76 | 36.76 | 0.50 | 0.51 | 0.53 | 0.50 |
| Quick Ratio | 36.76 | 36.76 | 0.50 | 0.51 | 0.53 | 0.50 |
| Cash Ratio | 36.76 | 36.76 | 0.07 | 0.07 | 0.06 | 0.03 |
| Asset Turnover | — | -0.01 | 0.12 | 0.13 | 0.03 | 0.01 |
| Inventory Turnover | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Dividend Yield | 5.4% | — | — | — | — | — |
| Payout Ratio | — | — | 26.9% | — | 2.8% | 4.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 3.7% | — | — | — | — | — |
| Total Shareholder Yield | 9.2% | — | — | — | — | — |
| Shares Outstanding | — | $9M | $28M | $24M | $22M | $19M |
Insurance liability actuarial volatility
According to recent market data, MLCI trades at a P/B ratio of 0.36, which suggests that investors are heavily discounting the firm's book value due to the persistent volatility and negative earnings trajectory inherent in its hybrid insurance-asset management business model compared to broader financial services peers.
The forward P/E of 14.04 implies an expectation of earnings recovery that appears disconnected from the firm's recent history of negative net income. This valuation gap suggests the market is pricing the company as a distressed insurance entity rather than a growing private credit platform, warranting caution regarding the sustainability of current price levels.
Based on reported figures, MLCI's ROIC has fluctuated wildly, reaching a low of -34.0% in 2025Q4, which indicates that the firm is currently failing to generate positive returns on its invested capital as it struggles to integrate its insurance float with proprietary credit strategies.
The erratic ROE and ROIC trends suggest that the company's capital allocation is being undermined by non-operating investment losses. Investors should monitor whether management can stabilize these returns as they rotate insurance assets into higher-yielding credit, as current performance appears structurally challenged compared to historical benchmarks.
As reported in financial statements, MLCI's asset turnover has remained near zero or negative over the last ten quarters, reflecting the significant accounting distortions caused by the consolidation of insurance investment portfolios rather than standard operational efficiency metrics seen in traditional asset management firms.
The lack of meaningful asset turnover suggests that the firm's primary value driver is not the velocity of its capital but the spread earned on its insurance liabilities. This makes traditional efficiency ratios largely irrelevant, as the business model is more akin to a balance-sheet-heavy spread arbitrage vehicle than a fee-based manager.
According to recent SEC filings, MLCI's D/E ratio of 1.03% appears deceptively low, yet this figure likely masks significant leverage held within the Ability Insurance subsidiary, which warrants further investigation into the total system-wide debt service obligations and potential covenant risks for the holding company.
The interest coverage ratio has frequently dipped into negative territory, suggesting that debt service is becoming increasingly uncomfortable during periods of market volatility. Investors should be wary of the firm's ability to maintain its leverage profile if the insurance block requires additional capital to meet actuarial reserve requirements.
The P/S ratio is the most commonly misapplied metric for MLCI, as it fails to account for the fact that headline revenue is heavily distorted by unrealized mark-to-market investment gains and losses, which obscures the firm's actual fee-earning power and underlying economic profitability.
Analysts should instead focus on Fee Related Earnings (FRE) or Distributable Earnings (DE) to assess the company's true cash-generating capacity. Relying on revenue-based multiples in this context may lead to erroneous conclusions about the firm's growth trajectory, as the top-line figures do not reflect the recurring nature of the asset management business.
Includes 30+ ratios · 5 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MLCI stock.
Mount Logan Capital Inc. Common Stock's current P/E ratio is -0.5x. This places it at the 50th percentile of its historical range.
Mount Logan Capital Inc. Common Stock's return on equity (ROE) is -82.1%. The historical average is 42.3%.
Based on historical data, Mount Logan Capital Inc. Common Stock is trading at a P/E of -0.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Mount Logan Capital Inc. Common Stock's current dividend yield is 5.45%.
Mount Logan Capital Inc. Common Stock has 480.5% gross margin and 717.0% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.